Akebia Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2012 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Akebia Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2024.
  • Akebia Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2025 was $2.19M, a 7.33% decline year-over-year.
  • Akebia Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2025 was $7.6M, a 17.3% decline year-over-year.
  • Akebia Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $7.78M, a 16.6% decline from 2023.
  • Akebia Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $9.32M, a 47.8% decline from 2022.
  • Akebia Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $17.8M, a 21.5% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $7.78M -$1.54M -16.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-13
2023 $9.32M -$8.53M -47.8% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-13
2022 $17.8M -$4.89M -21.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $22.7M -$1.73M -7.05% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-08-28
2020 $24.5M +$12.5M +105% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-08-28
2019 $11.9M -$7.12M -37.4% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $19M +$6.76M +55% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $12.3M +$6.46M +111% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $5.83M +$1.11M +23.6% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-26
2015 $4.71M -$1.3M -21.6% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 $6.01M +$4.45M +284% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-06
2013 $1.56M +$1.44M +1182% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 $122K Jan 1, 2012 Dec 31, 2012 10-K 2015-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.